Stock listing
Applied Biocode Corp.
Selected listing: 6598 · TWSE · TWD · TW
Applied Biocode Corp. (TWSE:6598), Health Technology. Latest release Aug 11, 2026: Applied BioCode Reports Record Financial Results for the First Half…
- Ticker
- TWSE:6598
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- TWSE
- Currency
- TWD
About Applied Biocode Corp.
Applied Biocode Corp. is a public company listed under the ticker 6598 on the Taiwan market. Applied Biocode focuses on biotechnology solutions, contributing to advancements in the field.
Latest news from Applied Biocode Corp.
Applied BioCode Reports Record Financial Results for the First Half of 2026; Revenue Increases 81% Year Over Year, Driven by Strong U.S. Molecular Diagnostics Growth
August 11, 2026
Applied BioCode Announces New Nucleic Acid Extraction Claim for KingFisher™ Flex Nucleic Acid Purification System with BioCode® Gastrointestinal Pathogen Panel (GPP)
January 14, 2025
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
April 15, 2024
Applied BioCode Announces Retirement of CEO Chris Bernard
March 21, 2024
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer
September 28, 2023
Research Applied Biocode Corp.
Applied Biocode Corp. company profile
View the public company page for Applied Biocode Corp. on 6ix.
Applied Biocode Corp. news
Read company news and market updates connected to Applied Biocode Corp..
Applied Biocode Corp. investor events
Find investor webinars, events, and replay context for Applied Biocode Corp..